|
DUBAI, UAE, April 9, 2026 /PRNewswire/ -- Blockchain for Good Alliance (BGA), the global non-profit initiative founded by Bybit, dedicated to leveraging blockchain for societal impact, convened global leaders, policymakers, and industry stakeholders at an exclusive private gathering held at the House of Lords in the Palace of Westminster, London.
The first of BGA's new initiatives, the Impact Leaders' Summits, the gathering marked a significant milestone in BGA's expansion into the UK ecosystem, bringing together senior figures across government, finance, technology, and international organisations to discuss the evolving role of blockchain in shaping transparent, accountable, and inclusive systems.
The evening was formally opened by John David Beckett Taylor, Baron Taylor of Warwick, with distinguished attendees including Kulveer Singh Ranger, Baron Ranger of Northwood, Manzila Pola Uddin, Baroness Mazila Uddin and former UK Member of Parliament Lisa Cameron, and key industry leaders including Helen Liu, Founder of BGA, founder of AB Finance, and former Co-CEO of Bybit.
Throughout the evening, speakers highlighted the importance of collaboration between public and private sectors in unlocking the full potential of blockchain technology, and a central highlight was BGA's first impact report, The State of Blockchain for Good: A View from the Alliance, authored by Glenn Tan, Director of Global Affairs at BGA.
"'Purpose over profit' was a phrase noted by BGA in their report that caught my attention," commented Lord Taylor in his opening speech. "The report outlines a clear shift within the blockchain industry, and organizations like BGA play a pivotal role in ensuring that technology does not only serve financial gain, but also the betterment of societies."
"As blockchain integrates into essential digital infrastructure, we must ensure these systems are built with a focus on collective benefit," said Lord Ranger, in the Summit's closing remarks. "I congratulate BGA on their publication, one that isn't just about technical milestones but a testament to how blockchain technology is already implemented and deployed in the world, and already changing lives."
Helen Liu, Founder of BGA, underscored the Alliance's role in convening global stakeholders and supporting projects that demonstrate both impact and scalability, noting that the next phase of blockchain adoption will be driven by solutions that are commercially viable and capable of operating at scale.
"The discussions tonight reinforced key principles championed by BGA," said Liu. "Initiatives focused on public good are not at odds with commercial success but rather that sustainable impact is achieved when solutions are both economically viable and widely adoptable."
Strengthening the UK as a Hub for Responsible Innovation
The event also highlighted the United Kingdom's growing position as a leading centre for financial innovation and regulatory leadership. With growing engagement between policymakers and blockchain ecosystems, the UK continues to play a pivotal role in shaping frameworks that balance innovation with accountability.
BGA's presence in the UK signals its commitment to contributing to this ecosystem by connecting global builders, institutional partners, and capital to accelerate the deployment of impactful blockchain solutions.
Looking Ahead
"The BGA Impact Leaders Summit is a new initiative of the Alliance in our global strategy," said Glenn Tan, Director of Global Affairs at BGA. "We look forward to convening future Summits across different regions to continue fostering global dialogue at the intersection of technology, governance, and impact capital."
As blockchain continues to mature, BGA remains focused on advancing initiatives that move beyond experimentation and toward scalable, real-world implementation, working alongside governments, international organisations, and industry leaders worldwide.
#Bybit / #TheCryptoArk / #BGA
Helen Liu addresses guests during the Blockchain for Good Alliance Impact Leaders' Summit at the UK House of Lords, sharing insights on advancing blockchain for societal impact.
About Blockchain for Good Alliance (BGA)
The Blockchain for Good Alliance (BGA) is a global nonprofit initiative founded by Bybit, dedicated to advancing blockchain as a tool to address real-world problems. By convening leaders, innovators, and organisations from across the blockchain industry, BGA seeks to drive innovation, collaboration and action toward a more sustainable and equitable world.
For more information:
Email: hello@chainforgood.org
Website: www.chainforgood.org
Twitter: www.x.com/chainforgood
LinkedIn: https://www.linkedin.com/company/blockchainforgoodalliance/
DUBAI, UAE, April 9, 2026 /PRNewswire/ -- Blockchain for Good Alliance (BGA), the global non-profit initiative founded by Bybit, dedicated to leveraging blockchain for societal impact, convened global leaders, policymakers, and industry stakeholders at an exclusive private gathering held at the House of Lords in the Palace of Westminster, London.
The first of BGA's new initiatives, the Impact Leaders' Summits, the gathering marked a significant milestone in BGA's expansion into the UK ecosystem, bringing together senior figures across government, finance, technology, and international organisations to discuss the evolving role of blockchain in shaping transparent, accountable, and inclusive systems.
The evening was formally opened by John David Beckett Taylor, Baron Taylor of Warwick, with distinguished attendees including Kulveer Singh Ranger, Baron Ranger of Northwood, Manzila Pola Uddin, Baroness Mazila Uddin and former UK Member of Parliament Lisa Cameron, and key industry leaders including Helen Liu, Founder of BGA, founder of AB Finance, and former Co-CEO of Bybit.
Throughout the evening, speakers highlighted the importance of collaboration between public and private sectors in unlocking the full potential of blockchain technology, and a central highlight was BGA's first impact report, The State of Blockchain for Good: A View from the Alliance, authored by Glenn Tan, Director of Global Affairs at BGA.
"'Purpose over profit' was a phrase noted by BGA in their report that caught my attention," commented Lord Taylor in his opening speech. "The report outlines a clear shift within the blockchain industry, and organizations like BGA play a pivotal role in ensuring that technology does not only serve financial gain, but also the betterment of societies."
"As blockchain integrates into essential digital infrastructure, we must ensure these systems are built with a focus on collective benefit," said Lord Ranger, in the Summit's closing remarks. "I congratulate BGA on their publication, one that isn't just about technical milestones but a testament to how blockchain technology is already implemented and deployed in the world, and already changing lives."
Helen Liu, Founder of BGA, underscored the Alliance's role in convening global stakeholders and supporting projects that demonstrate both impact and scalability, noting that the next phase of blockchain adoption will be driven by solutions that are commercially viable and capable of operating at scale.
"The discussions tonight reinforced key principles championed by BGA," said Liu. "Initiatives focused on public good are not at odds with commercial success but rather that sustainable impact is achieved when solutions are both economically viable and widely adoptable."
Strengthening the UK as a Hub for Responsible Innovation
The event also highlighted the United Kingdom's growing position as a leading centre for financial innovation and regulatory leadership. With growing engagement between policymakers and blockchain ecosystems, the UK continues to play a pivotal role in shaping frameworks that balance innovation with accountability.
BGA's presence in the UK signals its commitment to contributing to this ecosystem by connecting global builders, institutional partners, and capital to accelerate the deployment of impactful blockchain solutions.
Looking Ahead
"The BGA Impact Leaders Summit is a new initiative of the Alliance in our global strategy," said Glenn Tan, Director of Global Affairs at BGA. "We look forward to convening future Summits across different regions to continue fostering global dialogue at the intersection of technology, governance, and impact capital."
As blockchain continues to mature, BGA remains focused on advancing initiatives that move beyond experimentation and toward scalable, real-world implementation, working alongside governments, international organisations, and industry leaders worldwide.
#Bybit / #TheCryptoArk / #BGA
Helen Liu addresses guests during the Blockchain for Good Alliance Impact Leaders' Summit at the UK House of Lords, sharing insights on advancing blockchain for societal impact.
About Blockchain for Good Alliance (BGA)
The Blockchain for Good Alliance (BGA) is a global nonprofit initiative founded by Bybit, dedicated to advancing blockchain as a tool to address real-world problems. By convening leaders, innovators, and organisations from across the blockchain industry, BGA seeks to drive innovation, collaboration and action toward a more sustainable and equitable world.
For more information:
Email: hello@chainforgood.org
Website: www.chainforgood.org
Twitter: www.x.com/chainforgood
LinkedIn: https://www.linkedin.com/company/blockchainforgoodalliance/
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Blockchain for Good Alliance Hosted First Impact Leaders' Summit at UK House of Lords
|
Accomplished medical research leader will oversee NCCN programs to advance clinical trials and improve the quality, effectiveness, and accessibility of cancer care.
PLYMOUTH MEETING, Pa., April 9, 2026 /PRNewswire/ -- Today, the National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers devoted to patient care, research, and education—announced the selection of Nancy L. Lewis, MD, MBS, FACP, as new Chief Scientific Officer (CSO).
Dr. Lewis is an experienced biomedical researcher with expertise in clinical trials for treating solid tumors and hematologic malignancies. She most recently served as Senior Clinical Program Leader for Novartis Pharmaceuticals, after several years as an Associate Professor for various prestigious academic cancer centers. She holds degrees from Penn State University, Temple University School of Medicine, and Rutgers University. Dr. Lewis completed residency at the University of Rochester and Fellowship at Fox Chase Cancer Center—one of NCCN's founding Member Institutions.
"This is a pivotal time for cancer research; there are many successes to build on yet so much still to do. Dr. Lewis is the perfect person to oversee the work we do to foster innovation and knowledge discovery that improves the lives of people with cancer," said Crystal S. Denlinger, MD, CEO, NCCN. "She will be an important asset to our leadership team as she helps us ensure our research and clinical programs continue to advance outcomes in oncology around the world."
Dr. Lewis has previously been honored with awards from some of the foremost cancer organizations across the country, including the American Association for Cancer Research (AACR), The American Society of Clinical Oncology (ASCO), and the American Cancer Society (ACS).
As CSO, Dr. Lewis will assist in the NCCN Oncology Research Program (ORP) as well as key aspects of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) and NCCN Guidelines for Patients®. She will have oversight of the NCCN Biomarkers Compendium®; NCCN Radiation Therapy Compendium™, and NCCN Imaging Appropriate Use Criteria™. Dr. Lewis will also assist with NCCN's Continuing Medical Education Program and with relevant global and policy initiatives.
"I am thrilled to join the National Comprehensive Cancer Network and contribute to its extraordinary legacy of advancing high‑quality cancer care," said Dr. Lewis. "I look forward to working with NCCN's exceptional collaborators to tackle emerging challenges and drive innovative solutions that improve the lives of patients everywhere."
Dr. Lewis will succeed Dr. Denlinger who previously held the position of CSO before becoming CEO for the organization. Dr. Lewis will assume her new role in May 2026.
About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network® (NCCN®) is a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to defining and advancing quality, effective, equitable, and accessible cancer care and prevention so all people can live better lives. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) provide transparent, evidence-based, expert consensus-driven recommendations for cancer treatment, prevention, and supportive services; they are the recognized standard for clinical direction and policy in cancer management and the most thorough and frequently-updated clinical practice guidelines available in any area of medicine. The NCCN Guidelines for Patients® provide expert cancer treatment information to inform and empower patients and caregivers, through support from the NCCN Foundation®. NCCN also advances continuing education, global initiatives, policy, and research collaboration and publication in oncology. Visit NCCN.org for more information.
Media Contact:
Rachel Darwin
267-622-6624
darwin@nccn.org
Accomplished medical research leader will oversee NCCN programs to advance clinical trials and improve the quality, effectiveness, and accessibility of cancer care.
PLYMOUTH MEETING, Pa., April 9, 2026 /PRNewswire/ -- Today, the National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers devoted to patient care, research, and education—announced the selection of Nancy L. Lewis, MD, MBS, FACP, as new Chief Scientific Officer (CSO).
Dr. Lewis is an experienced biomedical researcher with expertise in clinical trials for treating solid tumors and hematologic malignancies. She most recently served as Senior Clinical Program Leader for Novartis Pharmaceuticals, after several years as an Associate Professor for various prestigious academic cancer centers. She holds degrees from Penn State University, Temple University School of Medicine, and Rutgers University. Dr. Lewis completed residency at the University of Rochester and Fellowship at Fox Chase Cancer Center—one of NCCN's founding Member Institutions.
"This is a pivotal time for cancer research; there are many successes to build on yet so much still to do. Dr. Lewis is the perfect person to oversee the work we do to foster innovation and knowledge discovery that improves the lives of people with cancer," said Crystal S. Denlinger, MD, CEO, NCCN. "She will be an important asset to our leadership team as she helps us ensure our research and clinical programs continue to advance outcomes in oncology around the world."
Dr. Lewis has previously been honored with awards from some of the foremost cancer organizations across the country, including the American Association for Cancer Research (AACR), The American Society of Clinical Oncology (ASCO), and the American Cancer Society (ACS).
As CSO, Dr. Lewis will assist in the NCCN Oncology Research Program (ORP) as well as key aspects of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) and NCCN Guidelines for Patients®. She will have oversight of the NCCN Biomarkers Compendium®; NCCN Radiation Therapy Compendium™, and NCCN Imaging Appropriate Use Criteria™. Dr. Lewis will also assist with NCCN's Continuing Medical Education Program and with relevant global and policy initiatives.
"I am thrilled to join the National Comprehensive Cancer Network and contribute to its extraordinary legacy of advancing high‑quality cancer care," said Dr. Lewis. "I look forward to working with NCCN's exceptional collaborators to tackle emerging challenges and drive innovative solutions that improve the lives of patients everywhere."
Dr. Lewis will succeed Dr. Denlinger who previously held the position of CSO before becoming CEO for the organization. Dr. Lewis will assume her new role in May 2026.
About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network® (NCCN®) is a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to defining and advancing quality, effective, equitable, and accessible cancer care and prevention so all people can live better lives. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) provide transparent, evidence-based, expert consensus-driven recommendations for cancer treatment, prevention, and supportive services; they are the recognized standard for clinical direction and policy in cancer management and the most thorough and frequently-updated clinical practice guidelines available in any area of medicine. The NCCN Guidelines for Patients® provide expert cancer treatment information to inform and empower patients and caregivers, through support from the NCCN Foundation®. NCCN also advances continuing education, global initiatives, policy, and research collaboration and publication in oncology. Visit NCCN.org for more information.
Media Contact:
Rachel Darwin
267-622-6624
darwin@nccn.org
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Nancy L. Lewis, MD, MBS, FACP, Named New Chief Scientific Officer for National Comprehensive Cancer Network (NCCN)
